---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-032245"
form_type: "8-K"
ticker: "PALI"
cik: "0001357459"
company_name: "PALISADE BIO, INC."
filed_at: "2023-09-11T23:59:59+00:00"
generated_at: "2026-06-10T21:37:36.322647+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Palisade Bio raises $1.97M in registered direct offering of 2.34M shares at $0.84/share

## Summary
- Gross proceeds of approximately $1.97 million from sale of 2,339,398 shares at $0.84 per share.
- Offering closed on September 11, 2023; proceeds for working capital and general corporate purposes.
- Ladenburg Thalmann acted as placement agent, receiving 7.75% cash fee and warrants to purchase 140,364 shares at $1.05.
- Shares offered under effective shelf registration statement on Form S-3 (File No. 333-263705).

## SEC filing metadata
- accession: 0001493152-23-032245
- form_type: 8-K
- ticker: PALI
- cik: 0001357459
- company_name: PALISADE BIO, INC.
- filed_at: 2023-09-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1357459/000149315223032245/0001493152-23-032245-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1357459/000149315223032245/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-032245
- JSON: https://secwatch.observer/filing/0001493152-23-032245.json
- Plain text: https://secwatch.observer/filing/0001493152-23-032245.txt

## Key facts
- Material Agreements
  PALISADE BIO, INC. entered into Securities Purchase Agreement with certain institutional investors valued at 2,339,398 shares at $0.84 per share for aggregate gross proceeds of approximately $1.97 million (effective 2023-09-07).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain institutional investors
  - Value: 2,339,398 shares at $0.84 per share for aggregate gross proceeds of approximately $1.97 million
  - Effective: 2023-09-07
  source text: Entry into a Material Definitive Agreement. Registered Direct Offering of Shares On September 7, 2023, Palisade Bio, Inc. (the “Company”) entered into securities purchase agreements (the “Purchase Agreements”) with certain institutional investors (the “Purchasers”), pursuant to which the Company agreed to sell and issue an aggregate of 2,339,398 shares (the “Shares”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”), at a purchase price per share of $0.84 (the “Offering”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1357459/000149315223032245/0001493152-23-032245-index.htm
- Material Agreements
  PALISADE BIO, INC. entered into Placement Agency Agreement with Ladenburg Thalmann & Co. Inc. valued at cash fee equal to 7.75% of gross proceeds, payment of up to $95,000 for certain expenses, and warran (effective 2023-09-07).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Ladenburg Thalmann & Co. Inc.
  - Value: cash fee equal to 7.75% of gross proceeds, payment of up to $95,000 for certain expenses, and warran
  - Effective: 2023-09-07
  source text: In connection with the Offering, we entered into a placement agency agreement (“Placement Agency Agreement”) with Ladenburg Thalmann & Co. Inc. (“Placement Agent”) whereby the Placement Agent receives (i) an aggregate cash fee equal to 7.75% of the gross proceeds received by the Company from the sale of the Shares, (ii) payment of up to $95,000 for certain expenses incurred in the Offering, and (iii) warrants to purchase up to 6.0% of the aggregate Shares sold in the Offering, or an aggregate of 140,364 placement agent warrants (the “Placement Agent Warrants”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1357459/000149315223032245/0001493152-23-032245-index.htm
- Material Agreements
  PALISADE BIO, INC. entered into Placement Agent Warrants with Ladenburg Thalmann & Co. Inc. valued at 140,364 warrants, term of five years, exercise price of $1.05 per share (effective 2023-09-07).
  - Action: entry
  - Counterparty: Ladenburg Thalmann & Co. Inc.
  - Value: 140,364 warrants, term of five years, exercise price of $1.05 per share
  - Effective: 2023-09-07
  source text: The Placement Agent Warrants have a term of five (5) years from the commencement of sales, an exercise price of $1.05 per share, and are not being registered pursuant to this Offering.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1357459/000149315223032245/0001493152-23-032245-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.